THE EFFECT OF VANCOMYCIN AND LINEZOLID ON THE TREATMENT AND OUTCOMES OF PRESUMED MRSA PNEUMONIA

被引：0
|
作者：
Kinney, Justin
Pop, Lia
Lowe, Andrew
机构：
来源：
CRITICAL CARE MEDICINE | 2015年 / 43卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
451
引用
收藏
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS ANALYSIS OF LINEZOLID VERSUS VANCOMYCIN IN THE TREATMENT OF NOSOCOMIAL PNEUMONIA CAUSED BY METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) BASED ON A PHASE 4 CLINICAL TRIAL
    Li, J.
    Li, J. Z.
    Gao, X.
    Solem, C. T.
    Niederman, M. S.
    Chastre, J.
    Myers, D. E.
    Wan, Y.
    Stephens, J. M.
    Haider, S.
    VALUE IN HEALTH, 2013, 16 (03) : A91 - A91
  • [42] Telavancin vs. linezolid in an animal model of severe MRSA pneumonia
    Battaglini, Denise
    Bassi, Gianluigi Li
    Pagliara, Francesco
    Meli, Andrea
    Yang, Hua
    Yang, Minlan
    Motos, Ana
    Bobi, Joaquim
    Aguilera, Elisabet
    Senussi, Tarek
    Miller, John
    Fernandez, Laia
    Vinas, Enric Barbeta
    Torres, Antoni
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [43] Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial
    Silvestri, L
    van Saene, HKF
    Milanese, M
    Fontana, F
    Gregori, D
    Oblach, L
    Piacente, N
    Blazic, M
    EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) : 921 - 926
  • [44] MRSA pneumonia: Better outcome through continuous infusion of vancomycin?
    Blot, S
    CRITICAL CARE MEDICINE, 2005, 33 (09) : 2127 - 2128
  • [45] Linezolide versus vancomycin in MRSA nosocomial pneumonia: Probably better - but . . .
    Epaulard, O.
    MEDECINE ET MALADIES INFECTIEUSES, 2012, 42 (05): : 239 - 240
  • [46] Cost-effectiveness analysis of linezolid versus vancomycin in the treatment of ventilator-associated pneumonia in Spain
    Grau, S
    Alvarez-Lerma, F
    De la Fuente, S
    Neipp, R
    Rubio-Terres, C
    VALUE IN HEALTH, 2004, 7 (06) : 759 - 759
  • [47] LENGTH OF STAY IN PATIENTS WITH INFLUENZA AND BACTERIAL PNEUMONIA RECEIVING VANCOMYCIN OR LINEZOLID
    Stoneman, Carly
    Winters, Shauna
    Labeff, Lauren
    Heidel, Eric
    Hamilton, Leslie
    CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [48] Pharmacokinetic–pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries
    A. Canut
    A. Isla
    C. Betriu
    A. R. Gascón
    European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 2227 - 2235
  • [49] Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: Comparative analysis of linezolid and vancomycin use
    Nasraway, SA
    Shorr, AF
    Kuter, DJ
    O'Grady, N
    Le, VH
    Cammarata, SK
    CLINICAL INFECTIOUS DISEASES, 2003, 37 (12) : 1609 - 1616
  • [50] Comparative efficacy of linezolid and vancomycin for endotracheal tube MRSA biofilms from ICU patients
    Fernandez-Barat, Laia
    Motos, Ana
    Panigada, Mauro
    Alvarez-Lerma, Francisco
    Vina, Lucia
    Lopez-Aladid, Ruben
    Ceccato, Adrian
    Li Bassi, Gianluigi
    Nicolau, David P.
    Lopez, Yuli
    Munoz, Laura
    Guerrero, Laura
    Soy, Dolors
    Israel, Trinidad
    Castro, Pedro
    Torres, Antoni
    CRITICAL CARE, 2019, 23 (1):
12345